Inventor
MEIZHONG JIN
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry7%
C07CAcyclic or carbocyclic compounds7%
C07KPeptides7%
PatentTitleYear
12,264,157Compounds and methods for the enhanced degradation of targeted proteins202512,054,493Hepatitis B antiviral agents202411,512,083Compounds and methods for the enhanced degradation of targeted proteins202211,352,351Compounds and methods for the targeted degradation of androgen receptor2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ARVINAS OPERATIONS INC (3)· patent assignee history
2022–2025Patents assigned to UNIV YALE (2)· patent assignee history
2022Patents assigned to ARVINAS INC (1)· patent assignee history
2022–2025Based in US· patent location history
2024Patents assigned to ENANTA PHARM INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARVINAS OPERATIONS INC | 3 | 2022–2025 |
| UNIV YALE | 2 | 2022–2025 |
| ARVINAS INC | 1 | 2022 |
| ENANTA PHARM INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2025 |